Cancers, Free Full-Text
Por um escritor misterioso
Descrição
Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.
Cancer-Free, Third Edition by Bill Henderson - Audiobook
Cancer Free Posters for Sale
Noninvasive detection of any-stage cancer using free glycosaminoglycans
Cancer Ribbon Colors: The Ultimate Guide
Detection of HPV-16 DNA by PCR in histologically cancer free lymph nodes from patients with cervical cancer. - Abstract - Europe PMC
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes, Breast Cancer Research
IARC – INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers - European Urology Focus
Detection and characterization of lung cancer using cell-free DNA fragmentomes
OncLive - Clinical Oncology News, Cancer Expert Insights
Cancers, Free Full-Text
Science and health for all children with cancer
Frontiers Hypoxia-Modified Cancer Cell Metabolism
de
por adulto (o preço varia de acordo com o tamanho do grupo)